Boothbay Fund Management’s Mersana Therapeutics MRSN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-13,622
| Closed | -$432K | – | 1678 |
|
|
2023
Q3 | $432K | Buy |
13,622
+13,221
| +3,297% | +$420K | 0.01% | 920 |
|
|
2023
Q2 | $33K | Buy |
+401
| New | +$33K | ﹤0.01% | 1472 |
|
|
2021
Q4 | – | Sell |
-911
| Closed | -$215K | – | 1898 |
|
|
2021
Q3 | $215K | Buy |
911
+268
| +42% | +$63.2K | 0.01% | 1292 |
|
|
2021
Q2 | $218K | Buy |
+643
| New | +$218K | 0.01% | 1306 |
|
|
2021
Q1 | – | Sell |
-613
| Closed | -$408K | – | 1469 |
|
|
2020
Q4 | $408K | Buy |
+613
| New | +$408K | 0.02% | 693 |
|
|
2020
Q2 | – | Sell |
-484
| Closed | -$71K | – | 933 |
|
|
2020
Q1 | $71K | Buy |
+484
| New | +$71K | 0.01% | 668 |
|